320 results on '"Lautsch, Dominik"'
Search Results
2. Applicability of Vericiguat to Patients Hospitalized for Heart Failure in the United States.
3. Comparison of Machine Learning Algorithms for Predicting Hospital Readmissions and Worsening Heart Failure Events in Patients With Heart Failure With Reduced Ejection Fraction: Modeling Study
4. Contemporary outpatient management of patients with worsening heart failure with reduced ejection fraction: Clinical outcome results from the CHART-HF study
5. Abstract 12512: Predictive Factors of Right Heart Catheterization to Diagnose Pulmonary Arterial Hypertension Using Least Absolute Shrinkage Selection Operator (LASSO) Regression
6. Contemporary outpatient management of patients with worsening heart failure with reduced ejection fraction: Rationale and design of the CHART-HF study
7. Prognostic Interplay Between COVID-19 and Heart Failure With Reduced Ejection Fraction
8. Out-of-pocket payments for part d covered medications by medicare fee-for-service beneficiaries with heart failure with reduced ejection fraction
9. Individualized HbA1c Goals, and Patient Awareness and Attainment of Goals in Type 2 Diabetes Mellitus: A Real-World Multinational Survey
10. Medication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data
11. Treatment patterns of patients with worsening heart failure with reduced ejection fraction.
12. Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective
13. Representativeness of the VICTORIA Trial Population in Clinical Practice: Analysis of the PINNACLE Registry
14. Patient-centered Outcomes in HFrEF Following a Worsening Heart Failure Event: A Survey Analysis
15. Abstract 12786: Contemporary Outpatient Management of Patients With and Without Worsening Heart Failure With Reduced Ejection Fraction Within A Single Integrated System: Results From Electronic Medical Record Data in the CHART-HF Study
16. Abstract 12185: Medication Changes And Reasons For No Medication Change Among Outpatients With Heart Failure With Reduced Ejection Fraction: Results From CHART-HF
17. Abstract 11701: Generalizability of the Victoria Trial and the US FDA Label for Vericiguat to Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in the United States
18. Abstract 9818: Use of Outpatient Intravenous Diuretic Therapy Among Patients With Heart Failure in the United States
19. Budget Impact Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Event
20. Lipid-lowering treatment and low-density lipoprotein cholesterol target achievement in patients with type 2 diabetes and acute coronary syndrome
21. Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with Metformin
22. Comparative Efficacy of Dual and Single Initiation of Add-On Oral Antihyperglycemic Agents in Type 2 Diabetes Uncontrolled on Metformin Alone: A Systematic Literature Review and Network Meta-Analysis
23. Excess healthcare resource utilization and costs for commercially insured patients with pulmonary arterial hypertension: A real‐world data analysis.
24. N‐terminal pro‐B‐type natriuretic peptide concentrations, testing and associations with worsening heart failure events.
25. Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH)
26. Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK
27. Use of guideline-recommended management in established coronary heart disease in the observational DYSIS II study
28. Diagnosing pulmonary arterial hypertension in the Real World
29. End-of-life healthcare resource utilization and costs in patients with PAH: a real-world analysis
30. Concordance between physician and patient reported presence of symptoms in patients with pulmonary arterial hypertension in the US, Europe and Japan
31. Health related quality of life in pulmonary arterial hypertension in the US, Europe and Japan
32. Low-density lipoprotein cholesterol target achievement in patients surviving an acute coronary syndrome in Hong Kong and Taiwan - findings from the Dyslipidemia International Study II
33. Do acute coronary events affect lipid management and cholesterol goal attainment in Germany?: Results from the Dyslipidemia International study II
34. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II
35. The association between social determinants of health and patient‐centred outcomes in adults with heart failure with reduced ejection fraction
36. Comparison of Machine Learning Algorithms for Predicting Hospital Readmissions and Worsening Heart Failure Events in Patients With Heart Failure With Reduced Ejection Fraction: Modeling Study
37. Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study
38. Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients
39. Suboptimal adherence to food restrictions requirements related to drug regimens for chronic diseases
40. CONTEMPORARY THERAPY OF PULMONARY ARTERIAL HYPERTENSION ACROSS THE GLOBE
41. Anticoagulant and Antiplatelet Use Among Hemodialysis Patients in the United States Without Medicare
42. Prevalence of potential familial hypercholesterolemia (FH) in 54,811 statin-treated patients in clinical practice
43. Available oral lipid-lowering agents could bring most high-risk patients to target: an estimate based on the Dyslipidemia International Study II-Italy
44. Outpatient versus inpatient intravenous diuretic therapy for heart failure in the United States
45. Comparison of Machine Learning Algorithms for Predicting Hospital Readmissions and Worsening Heart Failure Events in Patients With Heart Failure With Reduced Ejection Fraction: Modeling Study (Preprint)
46. Medication Trajectory and Treatment Patterns in Medicare Patients With Heart Failure and Reduced Ejection Fraction
47. Additional file 1 of Medication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data
48. THE ASSOCIATION BETWEEN SOCIAL DETERMINANTS OF HEALTH AND PATIENT-CENTERED OUTCOMES IN ADULTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION
49. Individualized HbA1c Goals, and Patient Awareness and Attainment of Goals in Type 2 Diabetes Mellitus: A Real-World Multinational Survey
50. N‐terminal pro‐B‐type natriuretic peptide testing patterns in patients with heart failure with reduced ejection fraction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.